Ping Chen

This inventor holds 23 USPTO granted patents and 6 published patent applications, plus 9 CIPO patents and 29 EPO patents, primarily in Drug Discovery. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Shapr & Dohme Corp.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping Chen. Retrieved from https://idiyas.com/inventor/ping-chen-6zhoqt6o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 9 (Patent Applications = 5)

EPO Patents = 29 (Patent Applications = 17)

Average Co-Inventor Count = 7.4

ph-index = 5

Forward Citations = 92(Granted Patents)

Location History:

Old Bridge, NJ (US) (1998)
Edison, NJ (US) (2010 - 2022)

Company Filing History:

22 out of 2,405

Merck Sharp + Dohme Corp.

Merck Shapr & Dohme Corp.

patent

4. 1 out of 70

Merck Sharp & Dohme LLC

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Orexin Receptor Agonists

IDO Inhibitors

Dipeptidyl Peptidase-IV

Aminotetrahydropyrans

Benzimidazole Derivatives

Heterocyclic Compounds

Cyclic Phosphonates

Crystalline Forms

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12552767 - 3-heteroaryl pyrrolidine and piperidine orexin receptor agonists (2026-02-17),

2. 12312332 - Heteroaryl pyrrolidine and piperidine orexin receptor agonists (2025-05-27),

3. 12264134 - Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (2025-04-01),

4. 12152019 - Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors (2024-11-26),

5. 11478461 - [1.1.1] bicyclo compounds as indoleamine 2,3-dioxygenase inhibitors (2022-10-25),

6. 9868733 - Azabenzimidazole tetrahydrofuran derivatives (2018-01-16),

7. 9765107 - Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases (2017-09-19),

8. 9556193 - Benzimidazole hexahydrofuro[3,2-b]furan derivatives (2017-01-31),

9. 9540364 - Benzimidazole tetrahydrofuran derivatives (2017-01-10),

10. 9527839 - Benzimidazole tetrahydropyran derivatives (2016-12-27),

11. 9403790 - Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes (2016-08-02),

12. 9382243 - Azabenzimidazole tetrahydropyran derivatives (2016-07-05),

13. 9290517 - Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives (2016-03-22),

14. 9181262 - Crystalline forms of a dipeptidyl peptidase-IV inhibitors (2015-11-10),

15. 8980929 - Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes (2015-03-17),

Title: The Innovative Journey of Ping Chen

Introduction: Ping Chen, a visionary inventor based in Edison, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Ping Chen's latest patents include groundbreaking inventions in the fields of renewable energy, artificial intelligence, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, Ping Chen has established himself as a leading figure in the tech industry, with a strong focus on creating solutions that address global challenges.

Collaborations: Throughout his career, Ping Chen has collaborated with top research institutions, universities, and leading tech companies to bring his inventions to life and make a positive impact on society.

Conclusion: Ping Chen's dedication to innovation and his passion for creating a better world through technology continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.